SeQuent Scientific

Sequent Scientific Q3 FY25 results: Revenue up 18.7% YoY to Rs 390.8 crore, Net profit declines 58.5% YoY

SeQuent Scientific consolidates ownership of subsidiaries in Sweden and Italy

N-VET AB and Alivira Italia SRL specialize in trading animal healthcare products, reinforcing SeQuent’s commitment to advancing its pharmaceuticals portfolio.

Sequent Scientific and Viyash Life Sciences announce merger to create animal pharma leader

Sequent Scientific shares surge nearly 9% following merger with Viyash Life Sciences

SeQuent Scientific hits 52-week high, surges nearly 9% in 20 minutes

SeQuent Scientific shares surge 7% after WHO pre-qualification approval for Albendazole API

SeQuent Scientific shares rise 3% on strong Q3 performance